| CYHS2501764 | 多替拉韦钠片 | | Tablet | Chemical Drugs(4) | Generic Drug | 2025-05-15 | | Anhui Biochem Bio-Pharmaceutical Co Ltd | | | view |
| JYHZ2500096 | 多替拉韦钠片 | | Tablet | Chemical Drugs | License Renew | 2025-04-24 | | GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV;Delpharm Poznan SA | | | view |
| CYHB2500817 | 多替拉韦钠片 | | Tablet | Chemical Drugs(4) | Supplementary Application | 2025-04-24 | | Jiangsu Hechen Pharmaceutical Co Ltd;Aurisco Pharmaceutical Co Ltd | | | view |
| CYHS2501437 | 多替拉韦钠片 | | Tablet | Chemical Drugs(4) | Generic Drug | 2025-04-15 | | NORTHEAST Pharmaceutical Group Shenyang NO1 Pharmaceutical Co Ltd | | | view |
| JYHB2500083 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2025-02-20 | | Viiv Healthcare BV;Glaxo Operations UK Ltd | | | view |
| JYHB2500082 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2025-02-20 | | Viiv Healthcare BV;Glaxo Operations UK Ltd | | | view |
| JYHB2500016 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2025-01-10 | | Viiv Healthcare BV;Delpharm Poznan SA | | | view |
| CYHS2404620 | 多替拉韦钠片 | | Tablet | Chemical Drugs(4) | Generic Drug | 2024-12-31 | | Shijiazhuang Lonzeal Pharmaceuticals Co Ltd | | | view |
| CYHS2404038 | 多替拉韦钠片 | | Tablet | Chemical Drugs(4) | Generic Drug | 2024-11-23 | | Jiangsu Aidea Pharmaceutical Co Ltd | | | view |
| CYHS2402993 | 多替拉韦钠片 | | Tablet | Chemical Drugs(4) | Generic Drug | 2024-09-10 | | Yangzhou Aurisco Pharmaceutical Co Ltd;Jiangsu Hechen Pharmaceutical Co Ltd | | | view |
| CYHS2401058 | 多替拉韦钠片 | | Tablet | Chemical Drugs(4) | Generic Drug | 2024-04-10 | | Shanghai DESANO Biopharmaceutical Co Ltd | | | view |
| JYHS2400014 | 多替拉韦钠片 | | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2024-04-02 | | Hetero Labs Ltd;Hetero Phrma (Beijing) Co Limited | | | view |
| JYHB2400126 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2024-03-15 | | Viiv Healthcare BV;Glaxo Operations UK Ltd | | | view |
| JYHB2400125 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2024-03-15 | | Viiv Healthcare BV;Glaxo Operations UK Ltd | | | view |
| JYHB2300538 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2023-09-20 | | Viiv Healthcare BV;Delpharm Poznan SA | | | view |
| JYHB2300044 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2023-01-13 | | Viiv Healthcare BV;Glaxo Operations UK Ltd | | | view |
| JYHB2300045 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2023-01-13 | | Viiv Healthcare BV;Glaxo Operations UK Ltd | | | view |
| JYHB2200686 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2022-12-31 | | Viiv Healthcare BV;Delpharm Poznan SA | | | view |
| CYHS2200638 | 多替拉韦钠片 | | Tablet | Chemical Drugs(4) | Generic Drug | 2022-04-24 | | QILU Pharmaceutical Co Ltd | | | view |
| JYHB2101115 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2021-05-26 | | Viiv Healthcare BV;Glaxo Operations UK Ltd | | | view |
